Research summary, original research, 2015

Radiation Exposure in Transjugular Intrahepatic Portosystemic Shunt Creation

Miraglia R, Maruzzelli L, Cortis K, D'Amico M, Floridia G, Gallo G, et al.. Cardiovascular and interventional radiology. 2015

Read the original paper

In plain language

In 347 transjugular intrahepatic portosystemic shunt (TIPS) patients at one center, ultrasound-guided portal vein puncture and newer flat panel systems were associated with lower patient dose-area product and shorter fluoroscopy time. Staff dose was not measured, though lower patient dose generally lowers scatter to the fluoroscopy team.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Size
n = 347 patients
Summary based on
the abstract

What it found

  • Fluoroscopy-guided portal vein targeting in an image intensifier system had the highest patient dose-area product compared with ultrasound-guided puncture.

    Key figures: Group I mean 360 ± 298 Gy cm2 vs Group II 217 ± 130 Gy cm2 (p = 0.002) vs Group III 129 ± 117 Gy cm2 (p < 0.001)

  • With ultrasound-guided puncture, a flat panel detector system gave lower dose-area product than an image intensifier system.

    Key figures: p < 0.001

  • Fluoroscopy time was longer with fluoroscopic targeting than with ultrasound-guided puncture, but did not differ between the two ultrasound-guided groups.

    Key figures: 25.78 ± 13.52 min vs 20.45 ± 10.87 min (p = 0.02) vs 19.76 ± 13.34 min (p < 0.001); Groups II vs III p = 0.73

Limits to keep in mind

Single-center retrospective comparison of non-randomized groups treated over different time periods (2007-2014), so operator experience and other changes may confound results. Only patient dose metrics were measured; staff dose was not assessed.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.